Cited by 23MicroRNA in disease regulationBone Metabolism and DiseasesOsteoarthritis Treatment and Mechanisms

MiR-30 family: a novel avenue for treating bone and joint diseases?

Open access
Huang, Jinming, Li, Yi, Zhu, Siyi, Wang, Liqiong, Yang, Lin, He, Chengqi·2023·International Journal of Medical Sciences

Abstract

Bone and joint diseases are a group of clinically heterogeneous diseases characterized by various bone strength disorders, bone structural defects and bone mass abnormalities. Common bone diseases include osteoporosis, skeletal dysplasia, and osteosarcoma, and common joint diseases include osteoarthritis, rheumatoid arthritis, and degenerative disc disease. all of them lead to high medical costs. The miR-30 family consists of a total of 5 members: miR-30a, miR-30b, miR-30c, miR-30d and miR-30e. Accumulating evidence has indicated that the miR-30 family may be involved in the occurrence and development of bone and joint diseases. For example, miR-30a is highly expressed in blood samples of osteoporosis patients, miR-30a/b increases in cartilage tissue of osteoarthritis patients, and lower expression of miR-30c is associated with higher malignance and shorter survival time of osteosarcoma. Mechanistically, by targeting crucial transcription factors (RUNX2, SOX9, beclin-1, etc.), the miR-30 family regulates some critical pathways of bone homeostasis (Wnt/β-Catenin, mTOR, PI3K/AKT, etc.). In view of the distinct actions of the miR-30 family on bone metabolism, we hypothesize that the miR-30 family may be a new remedy for the clinical treatment and prevention of some bone and joint diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7150/ijms.81990

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MSC-Exos reduces the expression of proinflammatory cytokines in immune cells, diminishing inflammation-induced delays in bone healing and promoting bone tissue regeneration.

    “Furthermore, MSC-Exos reduces the expression of proinflammatory cytokines in immune cells, thereby diminishing inflammation-induced delays in bone healing and promoting bone tissue regeneration [25,26].”

    From Hydrogel scaffold encapsulating MSC-Exos and ZIF-8 promotes bone regeneration via coordinating osteogenesis and immunomodulation (2025) · cites this paper as [25]

    The 'MiR-30 Family and Extracellular Vesicles of Different Origins' section discusses BMSC-derived vesicles in osteosarcoma and vesicles from other sources in arthritis, but does not report the claimed effect of MSC exosomes. Searches for cytokines in immune cells and inflammation-related delays in bone healing found no passage addressing that claim. Page numbers were not provided in our copy. (LLM, conf=0.75)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Huang, J., Li, Y., Zhu, S., Wang, L., Yang, L., & He, C.
Affiliations
Sichuan University (CN)
Corresponding author
  • Yang, Lin
  • He, Chengqi
Venue
International Journal of Medical Sciences
Published
2023
Volume
20
Issue
4
Pages
493-504
ISSN
1449-1907 (ISSN-L)
OpenAlex
W4320502761
Cited by
23
References
106
Citations by year
2026: 6 · 2025: 7 · 2024: 10
FWCI
0.73
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • International Journal of Medical Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (hx-h2107188, 81972146, 81902287, 2021YFS0004)
  • Department of Science and Technology of Sichuan Province (2021YFS0004)
  • Sichuan University (81972146, 2021YFS0004, 81902287, hx-h2107188)
  • West China Hospital, Sichuan University
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
Keywords
miR-30 family, bone and joint diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, intervertebral disc degeneration, osteosarcoma, skeletal dysplasia, miR-30a, miR-30c, miR-30d, miR-30e, bone homeostasis, Wnt/β-catenin signaling, mTOR signaling, PI3K/Akt signaling, Runx2, SOX9, Beclin-1, microRNA therapeutic target
MeSH terms
Bone Neoplasms, Humans, Osteoarthritis, Osteoporosis, Osteosarcoma, Phosphatidylinositol 3-Kinases, MicroRNAs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review